| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 16.077 | 22.896 | 9.499 | 0 | 2.028 | 15.670 | 21.162 |
| Total Income - EUR | - | - | 0 | 22.160 | 28.362 | 14.448 | 4.840 | 6.882 | 23.803 | 57.353 |
| Total Expenses - EUR | - | - | 0 | 18.623 | 16.804 | 13.997 | 4.840 | 5.603 | 22.466 | 34.130 |
| Gross Profit/Loss - EUR | - | - | 0 | 3.538 | 11.558 | 452 | 0 | 1.280 | 1.337 | 23.223 |
| Net Profit/Loss - EUR | - | - | 0 | 3.376 | 11.329 | 363 | 0 | 1.260 | 1.199 | 22.134 |
| Employees | - | - | 0 | 3 | 2 | 1 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Dermacare Proestet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 36.871 | 31.112 | 25.573 | 20.166 | 15.373 | 123.952 | 101.764 |
| Current Assets | - | - | 43.728 | 5.795 | 15.646 | 16.204 | 13.826 | 2.658 | 178.859 | 42.830 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 43.685 | 1.397 | 222 | 217 | 0 | 2.028 | 4.609 | 28.145 |
| Cash | - | - | 44 | 4.399 | 15.425 | 15.986 | 13.826 | 630 | 174.249 | 14.685 |
| Shareholders Funds | - | - | 44 | 3.419 | 14.681 | 14.766 | 14.226 | 1.300 | 2.496 | 24.615 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 0 | 2.376 | 1.385 | 1.850 | 3 | 1.762 | 186.090 | 23.212 |
| Income in Advance | - | - | 43.685 | 36.871 | 30.691 | 25.160 | 19.762 | 14.969 | 114.225 | 96.767 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dermacare Proestet Srl